Consumer Staples • Retail-Drug Stores and Proprietary Stores
$90.25 ▼ -0.08
(-0.09%)
MKT CAP: $115.53B • VOL: 8.19M
52W L $70 52W H $111
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$76
MEDIAN
$101
MEAN
$103
HIGH
$123
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE CVS TAPE
CVS // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $109.20 | $103.79 | 2025-02-14 | $82.13 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $113.72 | $106.49 | 2025-02-06 | $84.83 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $102.88 | $99.28 | 2025-01-29 | $86.64 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $92.06 | — | 2025-01-17 | $88.44 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $79.42 | $85.74 | 2025-01-09 | $80.32 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $107.40 | $93.86 | 2024-12-18 | $78.52 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $87.54 | $91.15 | 2024-12-04 | $83.93 | -4.3% | 48% | C |